Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What are the Key Projections for the CAGR of the Age-Related Macular Degeneration Market From 2025 to 2034?
Recent years have seen robust growth in the market size of age-related macular degeneration. This market, from 2024’s valuation of $9.96 billion, is predicted to expand to $10.7 billion in 2025, registering a compound annual growth rate (CAGR) of 7.5%. Growth during the historical period has been driven by factors such as the aging demographic, lifestyle and environmental changes, inherent genetic risks, heightened awareness, early detection, and progress in diagnostic methodologies.
Expectations are high for significant expansion in the age-related macular degeneration market in the coming years. With a projected compound annual growth rate (CAGR) of 7.7%, it is expected to reach $14.38 billion by 2029. The projected growth during the forecast period is largely due to advances in genetic and biomarker research, the growth of telemedicine and remote patient monitoring, and enhanced patient advocacy and education. The forecast period also anticipates trends such as tailor-made medical procedures, advancements in retinal image technology, the advent of continuous drug delivery systems, clinical experiments for investigative therapies, and collaborative efforts in research and development.
How Are the key drivers Contributing to the Expansion of the age-related macular degeneration Market?
The growth of the age-related macular degeneration (AMD) market is predicted to be fueled by an increasing prevalence of AMD. AMD is an eye condition that progresses with age and affects the macula, a tiny section of the retina responsible for central vision. Treatments for AMD help those struggling with retinal disorders by reducing the intensity of the disease. In February 2023, reports from UK-based laser eye treatment specialist, Optimaxa, stated that AMD impacted 196 million people worldwide. This number is projected to increase to 288 million by 2040, representing 8.7 percent of the global population. As a result, the expanding prevalence of AMD is pushing forward the AMD market’s growth.
Get Your Free Sample of the Global Age-Related Macular Degeneration Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10845&type=smp
What Are the Key Industry Players Leading the Charge in the Age-Related Macular Degeneration Market’s Growth?
Major companies operating in the age-related macular degeneration market include:
• F. Hoffmann-La Roche Ltd._x000D_
• Novartis AG_x000D_
• Bayer AG_x000D_
• Pfizer Inc._x000D_
• Bausch Health Companies Inc._x000D_
How Are Market Trends and Shifts Impacting the Growth Trajectory of the Age-Related Macular Degeneration Market?
Leading players in the AMD market are advancing innovative solutions, such as bispecific antibodies, in order to lessen the frequency of treatment. An example of bispecific antibodies is an artificially-engineered antibody which can bind to two diverse antigens at the same time. For instance, in May 2022, Chugai Pharmaceutical Co., Ltd., a pharmaceutical organization based in Japan, introduced Vabysmo intravitreal injection 120 mg/mL. This is a bispecific antibody developed for treating eye diseases such as AMD and DME. This revolutionary treatment functions by simultaneously focusing on two crucial pathways: angiopoietin-2 (Ang-2), that is responsible for unusual growth of blood vessels and inflammation, and Vascular Endothelial Growth Factor-A (VEGF-A), a significant component for new blood vessels creation that may result in vision loss. Vabysmo’s unique advantage is its prolonged dosing periods, facilitating treatments to be given every 16 weeks, thereby boosting patient convenience and compliance. Its two-pronged approach signifies a notable development in ophthalmic therapie, effectively addressing the critical necessity for trustworthy treatments in retinal diseases.
Get Instant Access to the Global Age-Related Macular Degeneration Market Report with Swift Delivery!
Which Growth-Oriented Segments of the Age-Related Macular Degeneration Market Are Leading the Industry’s Development?
The age-related macular degeneration market covered in this report is segmented –
1) By Type: Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)
2) By Drug: Eylea, Lucentis, Avastin, Other Products
3) By Route Of Administration: Intravenous, Intravitreal
4) By Distribution Channel: Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy
Subsegments:
1) By Wet Age-Related Macular Degeneration (AMD): Anti-VEGF Injections, Photodynamic Therapy, Laser Surgery
2) By Dry Age-Related Macular Degeneration (AMD): Nutritional Supplements, Low Vision Aids, Therapies For Geographic Atrophy
What Regions Are Influencing the Dynamics of the Age-Related Macular Degeneration Market?
North America was the largest region in the global age-related macular degeneration market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the age-related macular degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Key Elements Shape the Definition of the Age-Related Macular Degeneration Market?
Age-related macular degeneration (AMD) refers to a progressive eye condition in which the macula, which is located at the center of the retina, deteriorates over time in individuals with AMD, leading to a decline in central vision. It is due to aging. The therapy options for age-related macular degeneration include regular eye exams, lifestyle changes, and particular nutritional supplements.
Browse Through More Similar Reports By The Business Research Company:
Newborn Eye Imaging Systems Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/newborn-eye-imaging-systems-global-market-report
Post-Traumatic Stress Disorder Therapeutics Global Market Report 2024
Bleeding Disorders Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
